Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Hansa Biopharma
Hansa Biopharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Idefirix
Imlifidase
2020-08-25
Kidney transplantation
,
Immunologic desensitization
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Imlifidase
healthy volunteers/patients
,
duchenne muscular dystrophy
,
muscular dystrophies
,
kidney diseases
,
graft rejection
,
renal insufficiency
,
chronic kidney failure
,
guillain-barre syndrome
,
thrombotic thrombocytopenic purpura
,
thrombocytopenic purpura
,
purpura
,
retinal diseases
,
chronic renal insufficiency
,
cardiomyopathies
,
crigler-najjar syndrome
,
kidney transplantation
,
syndrome
,
hepatitis a
,
anti-glomerular basement membrane disease
,
infections
,
hiv infections
,
hepatitis c
,
chronic hepatitis c
,
communicable diseases
,
coinfection
,
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
chronic hepatitis
,
hemorrhage
,
headache
,
subarachnoid hemorrhage
Albumin
neoplasms
,
recurrence
,
glioblastoma
,
glioma
,
colorectal neoplasms
,
sarcoma
,
syndrome
,
leigh disease
,
urinary bladder neoplasms
,
non-muscle invasive bladder neoplasms
,
neoplasm metastasis
,
lung neoplasms
,
neuroendocrine tumors
,
perivascular epithelioid cell neoplasms
Lornoxicam
b-cell lymphoma
,
inflammatory breast neoplasms
,
immunoglobulin light-chain amyloidosis
,
amyloidosis
,
myeloproliferative disorders
,
primary myelofibrosis
,
promyelocytic leukemia acute
,
myelomonocytic leukemia chronic
,
myelomonocytic leukemia acute
,
myelomonocytic leukemia juvenile
,
acute disease
,
systemic scleroderma
,
diffuse scleroderma
,
sclerosis
,
large b-cell lymphoma diffuse
,
leukemia
,
myeloid leukemia acute
,
precursor cell lymphoblastic leukemia-lymphoma
,
myeloid leukemia
,
lymphoid leukemia
,
non-hodgkin lymphoma
,
lymphoma
,
myelodysplastic syndromes
,
multiple myeloma
,
plasma cell neoplasms
,
preleukemia
,
bcr-abl positive chronic myelogenous leukemia
,
neoplasms
,
b-cell chronic lymphocytic leukemia
,
triple negative breast neoplasms
,
renal insufficiency
,
hematologic diseases
,
blood protein disorders
,
neoplasms by histologic type
,
paraproteinemias
,
hodgkin disease
,
diabetes mellitus
,
type 1 diabetes mellitus
,
prolymphocytic leukemia t-cell
,
prolymphocytic leukemia
,
recurrence
,
burkitt lymphoma
,
graft vs host disease
,
bronchiolitis obliterans syndrome
,
anemia
,
aplastic anemia
,
breast neoplasms
,
brain stem neoplasms
,
glycogen storage disease type ii
,
glycogen storage disease type iii
,
glycogen storage disease
,
ovarian neoplasms
,
hematologic neoplasms
Sodium chloride
fibrosis
,
idiopathic pulmonary fibrosis
,
pulmonary fibrosis
,
acute lung injury
,
syndrome
,
thrombosis
,
catheter obstruction
,
respiratory distress syndrome
,
newborn respiratory distress syndrome
,
myocardial infarction
,
st elevation myocardial infarction
,
percutaneous coronary intervention
,
infarction
,
ventilator-associated pneumonia
,
pneumonia
Bevifimod
macular edema
,
edema
,
retinal diseases
,
diabetic retinopathy
Corticorelin
neuralgia
,
overactive urinary bladder
,
diabetic neuropathies
,
endometriosis
,
chronic cough
,
chronic renal insufficiency
,
renal insufficiency
,
healthy volunteers/patients
,
kidney diseases
,
chronic kidney failure
,
renal dialysis
,
thromboembolism
,
hemodiafiltration
,
hyperphosphatemia
,
colorectal neoplasms
Octagam
virus diseases
,
zika virus infection
,
anthrax
,
human influenza
,
h1n1 subtype influenza a virus
,
h3n2 subtype influenza a virus
,
vaccinia
,
hepatitis b
,
hepatitis
,
healthy volunteers/patients
,
smallpox
,
drug-related side effects and adverse reactions
,
respiratory tract infections
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use